MEGAN JARRELLS: Open Payments
NPI 1104663491 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,741 in 96 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $21 · 2025 $1,741
Food & beverage: $1,695Education: $46
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $627 |
| Medtronic, Inc. | 4 | $186 |
| Janssen Biotech, Inc. | 9 | $180 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $93 |
| Ardelyx, Inc. | 4 | $84 |
| Gilead Sciences, Inc. | 5 | $82 |
| Celltrion USA Inc. | 3 | $65 |
| Madrigal Pharmaceuticals | 2 | $54 |
| QOL Medical, LLC | 2 | $48 |
Products named: INTERSTIM, TREMFYA, SKYRIZI, XIFAXAN, RINVOQ, CREON, LINZESS, IBSRELA.
Industry payments across OH — which companies pay providers there.
